Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell)
ted.europa.eu
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varel...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 1, 2027
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 61964069711 Fax: +49 6966816559711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-01
TEN
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.09.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
Buyer: AB „Kelių priežiūra“ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-01
TenderProcurement ContractLithuaniaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 1, 2027
Buyer: AB „Kelių priežiūra“ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-01
GRA
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
grants.gov
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 2, 2027
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic studies would be supported. Therapeutic agents include small molecules, biologics or biotechnology-derived products. The goal of this NOFO is to spur therapeutic development for a variety of rare diseases by advancing projects to the point where they would attract subsequent investment supporting full Investigational New Drug (IND) application development or progression to clinical trials in the case of repurposing or repositioning.
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Aripiprazol in der Darreichungsform Depot-Injektionssuspension, ATC N05AX12 (Kopie)
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Adalimumab, ATC L04AB04
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Rivaroxaban Filmtabletten, ausgenommen in der Wirkstärke 2,5 mg, ATC B01AF01
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Erythropoietin alfa, ATC B03XA01
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Airpiprazol in der Darreichungsform Depot-Injektionssuspension, ATC N05AX12
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Pyridostigmin, ATC N07AA02
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Amifampridin, ATC N07XX05
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Blutzuckerteststreifen
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
TEN
Bulgaria – Medical consumables – Динамична система за покупки/ДСП/ : „Доставка на различни видове медицински изделия за нуждите на УМБАЛ " Света Екатерина“ ЕАД
ted.europa.eu
Buyer: Университетска многопрофилна болница за активно лечение "Света Екатерина" ЕАД | Notice type: cn-standard | Procedure: restricted | Contract: su...
TenderProcurement ContractBulgariaOpen
AmountNot provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glecaprevir und Pibrentasvir, ATC J05AP57 für die Zeit 01.09.2025 - 31.08.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ruxolitinib, ATC D11AH09 für die Zeit 01.09.2025 - 31.08.2027
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-07
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tafluprost + Timolol, ATC S01ED70 für die Zeit 01.09.2025 - 31.08.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Umeclidinum, ATC R03BB07 für die Zeit 01.09.2025 - 31.08.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Abrocitinib, ATC D11AH08 für die Zeit 01.09.2025 - 31.08.2027
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell)Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 61964069711 Fax: +49 6966816559711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-01
41780
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.09.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-VerfahrensBuyer: AOK NordWest | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-01
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AB „Kelių priežiūra“ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-01
41782
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic studies would be supported. Therapeutic agents include small molecules, biologics or biotechnology-derived products. The goal of this NOFO is to spur therapeutic development for a variety of rare diseases by advancing projects to the point where they would attract subsequent investment supporting full Investigational New Drug (IND) application development or progression to clinical trials in the case of repurposing or repositioning.
41783
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Aripiprazol in der Darreichungsform Depot-Injektionssuspension, ATC N05AX12 (Kopie)Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-03
41791
Bulgaria – Medical consumables – Динамична система за покупки/ДСП/ : „Доставка на различни видове медицински изделия за нуждите на УМБАЛ " Света Екатерина“ ЕАДBuyer: Университетска многопрофилна болница за активно лечение "Света Екатерина" ЕАД | Notice type: cn-standard | Procedure: restr...
Tender
Procurement Contract
Bulgaria
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glecaprevir und Pibrentasvir, ATC J05AP57 für die Zeit 01.09.2025 - 31.08.2027Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
